Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Astellas Mulls Potential Impact Of New US CRL For Izervay
Refiling Considered But Timing Unclear
Nov 19 2024
•
By
Lisa Takagi
Astellas received CRL over its sNDA for Izervay.
(Shutterstock)
More from Business
More from New Products